Top compounds associated with response to PFDN4


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.16 1e-06
mRNA barasertib CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.13 8e-05
mRNA ABT-737 CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0004
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.11 0.0004
mRNA indisulam CTRPv2 pan-cancer AAC -0.11 0.0005
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.1 0.0006
Download CSV